Foetal haemoglobin or haemoglobin F (HbF) is the major haemoglobin (Hb) at the foetal stage of human development, constituting approximately 90 per cent of total Hb. At birth, HbF constitutes approximately 59±10 per cent of the total Hb and continues to gradually decline thereafter, reaching an adult level of \<1 per cent by two years of age[@ref1][@ref2][@ref3]. These small amounts of HbF are not evenly distributed, but confined to a subpopulation of erythrocytes termed \'F cells\'. The F cell and HbF levels correlate well, and F cells at \<4.5 per cent of total erythrocytes corresponding to HbF at 0.6 per cent are generally observed in normal individuals[@ref2][@ref4].

Increased HbF and F cell levels can be observed in otherwise healthy adults in a condition known as \'hereditary persistence of foetal haemoglobin (HPFH)\'[@ref2]. Two types of HPFH, pancellular and heterocellular have been classified according to intraerythrocytic distribution of HbF[@ref2]. The intraerythrocytic distribution of HbF is the characteristics of pancellular HPFH, whereas only a subpopulation of erythrocytes containing HbF are observed in the heterocellular type.

Swiss-type HPFH is the heterocellular HPFH which is characterized by a modest increase in HbF levels in healthy adults[@ref2]. Although most of the HPFHs are not very common, the Swiss-type HPFH is frequently found in the general population as observed in 15 per cent of British twins and in 11.3-20.7 per cent of the Japanese individuals[@ref2][@ref5]. Increased HbF levels have been observed in both β-thalassaemia carriers and haemoglobin E (HbE) carriers[@ref6][@ref7]. A survey in Portugal among the β-thalassaemia carriers with increased HbF levels demonstrated significant association of high HbF trait with the *Xmn*I-^G^γ polymorphism and β-globin restriction fragment length polymorphism haplotypes[@ref8]. In contrast, a survey among HbE carriers in southern Thailand showed that increased HbF in HbE carriers was accounted for by both the*BCL11A* gene and the *Xmn*I-^G^γ polymorphism[@ref9]. Both β-thalassaemia and HbE carriers are common in Thailand[@ref10]. Therefore, these carriers could be screened in a population survey for HbF/F cell levels in Thailand and probably cause a broad range of HbF/F cell distribution. However, a detailed analysis of these F cell levels has not been performed. Therefore, this study was aimed to determine the F cell distribution in Thai blood donors who represent healthy Thai adults. The possible involvement of HbE and β-thalassaemia carriers in increased F cell levels was also studied.

Material & Methods {#sec1-2}
==================

Blood samples (3 ml) were collected in EDTA (ethylenediaminetetraacetic acid) from 375 blood donors (205 males and 170 females) at the Blood Bank Unit, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand from May 2002 to May 2004. The ethics clearance for this study was granted by the Research Ethics Committee, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand (number of 125/2002), and all participants signed the informed written consent.

*Automated determination of haemoglobin concentration and haematocrit*: Total haemoglobin concentration (Hb; g/dl), haematocrit (Hct; %) and mean corpuscular volume (MCV; fl) were determined using an automated blood cell analyzer (Sysmex KX-21 Hematology Analyzer; Sysmex Corporation, Kobe, Japan).

*F cell enumeration*: F cell levels were quantified by flow cytometric analysis of F cells after staining red blood cells (RBCs) in suspension with fluorescein isothiocyanate (FITC)-conjugated anti-γ-globin monoclonal antibody (mAb) following the procedure described previously with some modification[@ref2][@ref11]. Briefly, phosphate-buffered saline (PBS)-washed RBCs (\~130×10[@ref6] RBCs) were fixed in 4.0 per cent (v/v) formaldehyde, permeabilized in cold acetone:distilled water mix and stained with FITC-conjugated mAb against human γ-globin chain (gift from Dr Swee Lay Thein of King\'s College School of Medicine, London). The stained erythrocytes (\~2.6×10[@ref6] RBCs) were then washed and finally stored in 1.0 ml of 1.0 per cent formaldehyde in 0.1 bovine serum albumin (Sigma-Aldrich, USA) in PBS *p*H 7.4 for subsequent flow cytometric analysis (15,000 stained erythrocytes) using FACSCalibur™ coupled with CellQuest™ program (Becton-Dickinson, NJ, USA) ([Fig. 1](#F1){ref-type="fig"}).

![Flow cytometric histogram of F cells in normal (**A**) and elevated F cell levels (**B-D**). B and C are representative histograms of moderately high F cell levels observed in adult with heterocellular hereditary persistence of foetal haemoglobin. D is a representative histogram of extremely high F cell levels observed in cord blood.](IJMR-150-161-g001){#F1}

*Identification of β-thalassaemia carriers and HbE carriers*: β-thalassaemia and HbE carriers were identified from blood samples by cation exchange high performance liquid chromatography (HPLC) (Primus Variant System 99™, Primus Corporation, Kansas, USA) following manufacturer\'s instruction. HbE and A~2~ were co-eluted in this system. Blood samples of HbE carriers have HbA and E (plus A~2~). In contrast, blood samples having Hb types of A~2~A with HbA~2~ between 3.5 and 10 per cent were diagnosed as β-thalassaemia carriers[@ref1].

*Statistical analysis*: The data were analyzed for mean, standard deviation, unpaired Student\'s *t* test and Mann-Whitney U-test using SPSS 7.5 for Windows (SPSS Inc., Chicago, IL, USA).

Results {#sec1-3}
=======

*Levels of Hb, Hct and MCV*: Hb, Hct and MCV levels in all as well as male and female blood donors are shown in [Table](#T1){ref-type="table"}. Hb and Hct levels were significantly higher in males than females (*P*\<0.05). In contrast, MCV levels were significantly higher in females than males (*P*\<0.05).

###### 

Levels of haemoglobin (Hb) concentration, haematocrit (Hct) and mean corpuscular volume (MCV) in all blood donors, male blood donors (males) and female blood donors (females)

  Blood donors    Hb (g/dl)      Hct (%)       MCV (fl)
  --------------- -------------- ------------- --------------
  All (375)       13.7±1.2       41.3±3.1      86.8±7.5
  Males (205)     14.4±1.1^\*^   42.9±2.8^†^   86.0±7.7
  Females (170)   12.9±0.8       39.4±2.3      87.7±7.1^\$^

Values are mean±SD. ^\*,†^*P*\<0.05 compared to females ^\$^*P*\<0.05 compared to males

*F cell distribution*: F cell levels varied remarkably (0.8 - 39.2%) with positively skewed distribution in all individuals as well as in each gender ([Fig. 2](#F2){ref-type="fig"}). One hundred and twenty individuals or 32 per cent had F cell levels ≥4.5 per cent, the cut-off point previously established in studies among British and Japanese[@ref12]. Females had significantly higher F cell levels than males (5.1±4.8% vs. 4.1±3.5%).

![Distribution of F cell levels in 375 Thai blood donors (**A**) and in each gender (**B**). Note that the F cell distribution is wide and positively skewed. AU, arbitrary unit.](IJMR-150-161-g002){#F2}

*F cell levels in individuals with different MCV values*: The individuals were classified by the MCV cut-off point of 80 fl for thalassaemia trait[@ref1][@ref2]. The first group comprised 324 individuals having MCV ≥80 fl and the second group consisted of 51 individuals having MCV \<80 fl. Ninety nine individuals (30.5%) in the first group had high F cell levels (7.9±3.4%) compared to the remaining 225 individuals (69.5%) that had normal F cell levels (2.6±0.9%). In addition, 23 individuals (45.1%) in the second group had high F cell levels (11.7±9.1%), while the remaining 28 individuals (54.9%) had normal F cell levels (2.4±0.8%) ([Fig. 3](#F3){ref-type="fig"}). The average F cell level of the second group (low MCV) was significantly higher than that ofthe first group (6.6±7.6 vs. 4.3±3.2, *P*\<0.05).

![F cell levels in individuals having different mean corpuscular volume (MCV) values. Mean values are placed at the middle of each bar. Note that increased F cell levels are seen in both groups. FC, F cell.](IJMR-150-161-g003){#F3}

*F cell levels in β-haemoglobinopathies and normal*: The individuals having MCV \<80 fl had higher F cell levels than those having normal MCV values. F cell levels were compared between seven β-HbE and 32 normal individuals. It was found that F cell levels in these β-HbE were significantly higher than those in normal individuals (11.8±12.5% vs. 5.8±4.2%, *P*\<0.05).

Discussion {#sec1-4}
==========

In this study blood donors were used to represent healthy adults. All the individuals were not anaemic as shown by normal Hb/Hct levels. Thus, erythroid expansion should not be the cause of increased F cell production in these individuals[@ref2]. Elevated F cell levels observed might have resulted from HPFH, β-haemoglobinopathies (β-thalassaemia and HbE carriers) and malarial selection, either alone or in combination.

The HPFH can be identified by measuring F cell levels by FACS analysis[@ref12]. In contrast, identifying the HbE and β-thalassaemia carriers is conventionally performed by determining the Hb types and quantities using either cation-exchange HPLC[@ref13] or capillary zone electrophoresis (CZE)[@ref14]. HbA~2~ levels of 2.6±0.36 and 5.5±1.26 per cent are observed in normal individuals and β-thalassaemia carriers, respectively. In contrast, HbE plus HbA~2~ of 27.8±7.50 per cent are characteristics of HbE carriers[@ref14][@ref15]. The positively skewed distribution of F cell levels observed in this study was as expected. However, the presence of increased F cell trait observed in this study was higher than that demonstrated for the British and Japanese (32 vs. 10-20%)[@ref5][@ref16]. Thus, in addition to the Swiss-type HPFH, the β-HbE (β-thalassaemia and HbE carriers) and malarial selection were expected to be involved. Thailand is rich of β-HbE (particularly HbE and β-thalassaemia), the disorders accompanied by increased HbF and F cell levels due to an erythroid expansion[@ref17]. Thus, F cell status in Thai healthy adults is expected to be affected by not only the Swiss-type HPFH but also by these two β-HbE.

The surveys have clearly demonstrated that not only erythroid expansion but also HPFH cause increased HbF/F cell production in the β-HbE[@ref8][@ref9]. The *Xmn*I polymorphism has been shown to be the major genetic factor for the Swiss-type HPFH[@ref5]. However, the Kruppel-like factor 1 (*KLF1*) was also found to be involved in this type of HPFH[@ref18]. The *KLF1* is, in fact, an erythroid transcriptional factor first described in 1993. Although being the multifunctional nuclear protein in erythroid cells, one of its important functions is to promote the γ to β-globin gene switch[@ref19]. Thus, mutations of the *KLF1* gene terminate or retard the transition from γ to β-globin gene expression, leading to persistent expression of the γ-globin gene of the Swiss-type HPFH[@ref18]. *KLF1* mutations were found to be common in β-thalassaemia endemic area in China[@ref20]. Therefore, high F cell levels in β-thalassaemia, and HbE carriers, observed in this study, might also be accounted for by the *KLF1* mutations, in addition to the *Xmn*I polymorphism and the erythroid expansion. Study in detail is needed to elucidate this notion.

Ninety nine of 324 individuals (30.5%) having MCV ≥80 fl had increased F cell levels. These individuals were normal having less chance to be β-thalassaemia or HbE carriers. Therefore, in addition to the Swiss-type HPFH, malarial selection was expected to be involved in these individuals. Basically, RBCs containing high HbF are shown to have impaired cytoadherence property which reduces parasite density and ameliorates the clinical symptoms[@ref21]. Thus, those having high HbF in the RBCs should be selected and survive as malaria is common in northern Thailand[@ref22].

In conclusion, this study showed that in addition to the Swiss-type HPFH, the β-HbE (β-thalassaemia, HbE) were possibly involved in increased F cell levels. Therefore, the β-thalassaemia and HbE need to be considered in interpreting the F cell status in patients living in areas endemic of these disorders. However, sample size of the β-thalassaemia and HbE carriers analyzed in this study was small. Therefore, a study with a large sample size of these disorders should be performed to confirm these findings. Malarial involvement of elevated F cell levels should also be investigated in detail.
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